Skip to main content

IRB Barcelona's European research into cancer

Images

Participants

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

The 2017 Issue of the European Biotechnology magazine on the Life Sciences and Industry features recent studies conducted at IRB Barcelona by Oriol Gallego, research associate with the Translational Control of Cell Cycle and Differentiation Lab, and Salvador Aznar Benitah, ICREA researcher and group leader of the Stem Cells and Cancer Lab.

The magazines also includes a news piece about the research collaboration between Eduard Batlle's laboratory and the clinical-stage immuno-oncology company devoted to innovative bispecific antibody therapeutics Merus N.V., to develop antibodies targeting the tumour microenvironment.

Link to European Biotechnology (Eduard Batlle, page 63; Oriol Gallego, page 66; and Salvador Aznar Benitah, page 80)

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).